Skip to main content
. 2017 May 21;23(19):3440–3448. doi: 10.3748/wjg.v23.i19.3440

Table 1.

Cell lines sources and maintenance

Cell line Source Media FBS % Additives
MCF7 France1 DMEM 10% 1% P/S
1001 France DMEM 10% 1% P/S
ZR-75-1 Helsinki2 RPMI 1640 10% 1% P/S + Sodium pyruvate (1 mmol/L)
RKO Horizon3 RPMI 1640 10% 1% P/S + Sodium pyruvate (1 mmol/L)
RKO.p53-/- Horizon RPMI 1640 10% 1% P/S + Sodium pyruvate (1 mmol/L)
HCT116 Horizon RPMI 1640 10% 1% P/S + Sodium pyruvate (1 mmol/L)
HCT116.p53 Horizon DMEM 10% 1% P/S + 50% F12
HeLa France DMEM 10% 1% P/S
MDA-MB-361 France DMEM 10% 1% P/S
MDA-MB-231 France/ATCC DMEM 10% 1% P/S + 50% F12 + insulin (10 mg/mL in 25 mmol/L HEPES) + hydrocortisone (0.5 μg/mL)
CAL-51 Helsinki DMEM 20% 1% P/S
T47D France DMEM 10% 1% P/S + 50% F12 + EGF (20 ng/mL)
BT-549 Helsinki RPMI 1640 10% 1% P/S + Sodium pyruvate (1 mmol/L) + insulin (10 mg/mL in 25 mmol/L HEPES)
SW480 Helsinki DMEM 10% 1% P/S + 50% F12 + insulin (10 mg/mL in 25 mmol/L HEPES) + hydrocortisone (0.5 μg/mL) + EGF (20 ng/μL)
1

France: Kind Gift from Professor Salem Chouaib, Institute Gustave Roussy, France;

2

Helsinki: Kind gift from Professor Paivi peltomaki; Department of Medical Genetics, Helsinki University, Finland;

3

Horizon Discovery, Cambridge, United Kingdom.